Kirsten Gruis
Equibles does not estimate personal net worth.
About Kirsten Gruis
DiaMedica Therapeutics Inc. reported in an 8-K filed September 5, 2023 that Kirsten Gruis resigned as Chief Medical Officer, effective August 31, 2023. The proxy statement of DiaMedica Therapeutics Inc. reports total compensation of $596,083 for Kirsten Gruis in fiscal 2023, including a base salary of $298,643. Disclosed compensation is on record for 2 fiscal years.
“On September 3, 2023, Kirsten Gruis, M.D. resigned from her position as Chief Medical Officer of DiaMedica Therapeutics Inc. (“DiaMedica” or the “Company”), effective as of August 31, 2023, although she agreed to stay on as an independent consultant with the Company for nine months to assist with the transition of her duties and responsibilities and to complete certain additional projects.”
Affiliation history
-
DiaMedica Therapeutics Inc. (DMAC)
Source not stated
Start not stated–2023-08-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | DiaMedica Therapeutics Inc. (DMAC) | Former Chief Medical Officer | $298,643 | $596,083 |
| 2022 | DiaMedica Therapeutics Inc. (DMAC) | Former Chief Medical Officer | $364,167 | $1,004,691 |